3
46
S. Samadi et al. / Journal of Catalysis 340 (2016) 344–353
Ar), 7.43–7.46 (2H, d, J = 8.5 Hz), 7.76–7.79 (2H, d, J = 8.5 Hz); 13C
NMR (75 MHz, DMSO-d ): d (ppm) = 28.5, 56.3, 64.9, 80.0, 117.4,
27.3, 127.4, 128.5,128.7, 128.9, 141.9, 142.7, 143.8, 153.1, 166.2.
4.54–4.64 (1H m), 6.68 (1H s, NH), 7.25–7.34 (5H m, Ar), 7.42–
6
C
7.45 (2H, d, J = 8.3 Hz), 7.89–7.92 (2H d, J = 8.4 Hz); IR (KBr,
ꢁ1
1
cm ): 1516, 1638, 1724, 2920, 2979, 3360; MS m/z (%): 353 (M,
ꢁ
1
IR (KBr, cm ): 1516, 1630, 1704, 2632, 2977, 3355.
S)-tert-butyl (4-((1-hydroxy-3-phenylpropan-2-yl)carbamoyl)
phenyl)carbamate (6b): Mp: 167–170 °C,
CDCl ): d (ppm) = 1.53 (9H, s), 2.98–3.00 (2H, brd, J = 6.8 Hz),
100), 297 (73), 261 (42), 205 (62), 161 (33), 91 (27), 57 (61).
(
(S)-tert-butyl (4-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)car-
1
1
H
NMR (300 MHz,
bamate (7c): H NMR (300 MHz, CDCl
3
): d
H
(ppm) = 0.83–0.86
3
H
(3H, d, J = 6.7 Hz), 0.93–0.95 (3H, d, J = 6.6 Hz), 1.41 (9H, s), 1.78–
3
3
.66–3.72 (1H, dd, J = 10.9, 5.2 Hz), 3.77–3.82 (1H, dd, J = 10.9,
.0 Hz), 4.34 (1H, m), 6.38–6.40 (2H, brd, J = 7.1 Hz, NH), 6.74
1.80 (1H, m), 4.04–4.08 (1H, m), 4.31 (1H, m), 4.81 (1H, brs),
7.39–7.82 (5H, m); IR (KBr, cm ): 1528, 1638, 1704, 2925, 2974,
3363.
ꢁ1
(
1H, s, NH), 7.25–7.32 (5H, m, Ar), 7.37–7.40 (2H, d, J = 8.4 Hz),
7
=
1
1
.59–7.62 (2H, d, J = 8.4 Hz); 13C NMR (75 MHz, CDCl
28.3, 37.0, 53.4, 64.4, 81.1, 117.7, 126.8, 128.1, 128.3, 128.8,
3
): d
C
(ppm)
(S)-tert-butyl (4-(4-isobutyl-4,5-dihydrooxazol-2-yl)phenyl)car-
1
bamate (7d): H NMR (300 MHz, CDCl
3
): d
H
(ppm) = 0.93–0.97
ꢁ1
29.3, 137.6, 141.6, 152.3, 167.6; IR (KBr, cm ): 1513, 1627,
(6H, m), 1.25 (9H, s), 1.32–1.39 (1H, m), 1.64–1.81 (2H, m), 3.89–
3.94 (1H, m), 4.20–4.31 (1H, m), 4.40–4.46 (1H, m), 6.60–6.62
698, 2634, 2979 3355; MS m/z (%): 370 (M, 6), 279 (36), 220
13
(
57), 164 (93), 120 (72), 91 (57), 57 (100).
S)-tert-butyl(4-((1-hydroxy-3-methylbutan-2-yl)carbamoyl)
(2H, brd, J = 8.7 Hz), 7.70–7.72 (2H, brd, J = 8.6 Hz).
C NMR
(
(75 MHz, CDCl
3
): d
C
(ppm) = 22.7, 23.0, 25.5, 29.4, 45.7,53.4, 64.8,
1
ꢁ1
phenyl)carbamate (6c): Mp: 157–160 °C,
CDCl ): d (ppm) = 1.02–1.06 (6H, t, J = 6.1 Hz), 1.54 (9H, s), 2.00–
.06 (1H, m), 3.81 (2H, brs), 3.94 (1H, brs), 6.29–6.31 (1H, brd,
J = 7.2 Hz, NH), 6.7 (1H, s, NH), 7.43–7.46 (2H, d, J = 7.9 Hz), 7.72–
H
NMR (300 MHz,
72.8, 114.1, 117.5, 129.8, 149.4, 163.5; IR (KBr, cm ): 1516,
1633, 2917, 2957, 3426.
3
H
2
.75 (2H, d, J = 8 Hz). 1 C NMR (75 MHz, CDCl
3
(ppm) = 19.1,
7
1
1
3
): d
C
2.2.3. Typical procedure for the synthesis of 4-oxazolinylaniline ligands
8a–8d
9.7, 28.3, 29.3, 57.6, 64.1, 81.2, 117.8, 128.4, 128.6, 141.6, 152.2,
ꢁ1
67.9; IR (KBr, cm ): 1513, 1619, 1699, 2656, 2983, 3343.
S)-tert-butyl(4-((1-hydroxy-4-methylpentan-2-yl)carbamoyl)
A portion of 2.8 mmol (1 g) of (S)-tert-butyl (4-(4-phenyl-4,5-
dihydrooxazol-2-yl)phenyl) carbamate 7a was placed in a round-
bottom flask (25 ml) containing 6:1 dichloromethane:trifluoroace
tic acid (9 ml). The reaction solution was stirred for 3 h at room
temperature. After completion of the reaction (as determined by
TLC analysis), 10 ml of water was added. The organic layer was
washed with 10 ml of aqueous sodium hydrogen carbonate (5%)
and then dried over Na SO to yield a concentrated light yellow
(
1
phenyl)carbamate (6d): Mp: 150–152 °C,
CDCl ): d (ppm) = 0.95 (3H, brs), 0.97 (3H, brs), 1.2–1.31 (1H,
m), 1.53 (9H, s), 1.63–1.72 (2H, m), 3.60–3.65 (1H, dd, J = 10.6,
H NMR (300 MHz,
3
H
5
6
.6 Hz), 3.74–3.79 (1H, dd, J = 10.6, 3.0 Hz), 4.244.25 (1H, m),
.34 (1H, d, J = 8.0 Hz, NH), 6.87 (1H, s, NH), 7.39–7.42 (2H, d,
13
J = 8.3 Hz), 7.68–7.71 (1H, d, J = 8.3). C NMR (75 MHz, CDCl
3
): d
C
2
4
(
ppm) = 22.3, 23.1, 25.0, 28.3, 40.3, 50.4, 66.2, 81.1, 117.8, 128.1,
oil. Purification using flash chromatography (30–40% EtOAc/n-
hexane) afforded a light yellow product 8a in 85% yield. Com-
pounds 8b–8d were synthesized by a similar method. The yields
ꢁ
1
1
2
28.3, 141.6, 152.4, 167.7; IR (KBr, cm ): 1516, 1635, 1710,
860, 2957, 3445.
for other products were 84%, 93%, and 86%, respectively [30].
1
2
.2.2. Typical procedure for the synthesis of compounds 7a–7d
A flame-dried round-bottom flask with a stirrer bar was
(S)-4-(4-phenyl-4,5-dihydrooxazol-2-yl)aniline (8a):
(300 MHz, CDCl ): d
H NMR
3
H
(ppm) = 4.21–4.26 (1H, t, J = 8.0 Hz), 4.73–
charged with white hydroxy amid 6a (3.5 mmol, 1.1 g, 1 equiv),
-(dimethylamino) pyridine (0.02 g, 0.18, 0.1 equiv) and CH Cl
10 ml) under N . Triethylamine (1.1, 7.7 mmol, 2.2 equiv) was
4.79 (1H, t, J = 9.1 Hz), 5.32–5.38 (1H, m), 6.68–6.71 (2H, d,
J = 8.0 Hz), 7.28–7.36 (5H, m, Ar), 7.84–7087 (2H, d, J = 8.1 Hz);
C NMR (75 MHz, DMSO-d ): d (ppm) = 69.9, 74.7, 113.8, 126.8,
6 C
4
(
2
2
1
3
2
added to mixture of reaction. The flask was placed in ice, and a
128.7, 130.2, 131.7, 142.8, 149.8, 151.3, 166.5; MS m/z (%): 239
solution of p-toluenesulfonyl chloride (0.67 g, 3.5 mmol, 2 equiv)
(M + 1, 100), 208 (75), 180 (20), 120 (63), 89 (30), 65 (23);
D
in 4 ml of CH
stirred at room temperature for 12 h. The reaction mixture was
diluted with 10 ml of CH Cl , and upon washing with 10 ml of sat-
urated aqueous NH Cl, two layers were separated, and the aqueous
layer was extracted again with CH Cl
(2 ꢀ 5 ml). The combined
organic extracts were washed with 10 ml of saturated aqueous
NaHCO , the organic layer was dried over Na SO , and a concen-
2
Cl
2
was added. The light yellow clear solution was
[a]
20 = +40.3° (c 1.0, CH
2
Cl
2
).
(S)-4-(4-benzyl-4,5-dihydrooxazol-2-yl)aniline (8b): 1H NMR
(300 MHz, CDCl ): d (ppm) = 2.94–3.02 (1H, m), 3.22–3027 (1H,
m), 4.60–4.82 (3H, m), 6.60–6.63 (2H, d, J = 8.5 Hz), 7.19–7.34
2
2
3
H
4
1
3
2
2
(5H, m), 7.75–7.81 (2H, d, J = 8.8 Hz); C NMR (75 MHz, CDCl
3
):
d
C
(ppm) = 34.8, 70.3, 73.1, 109.9, 123.3, 124.8, 125.2, 128.7,
3
2
4
129.8, 131.8, 141.3, 151.3, 166.1; MS m/z (%): 253 (12.5, M + 1),
trated, light yellow oil was achieved and purified by column chro-
matography (25–75% EtOAc/n-hexane) to afford a pure light yellow
product 7a in 85% yield. Compounds 7b–7d were synthesized by a
similar method. The total yields were 85%, 80%, and 95%, respec-
tively [14–16].
216 (11.25), 179 (79.7), 161 (93.8), 133 (37.5), 120 (100), 106
D
(31.3), 91 (76.5), 65 (51.3); [
a
]
20 = +10.7° (c 1.0, CH
2
Cl
2
).
(S)-4-(4-isopropyl-4,5-dihydrooxazol-2-yl)aniline (8c): 1H NMR
(300 MHz, CDCl ): d (ppm) = 0.97–0.99 (3H, d, J = 6.7 Hz), 1.03–
3
H
1.1 (3H, d, J = 6.7 Hz), 2.05–2.11 (1H, m), 4.37–4.42 (1H, m),
(
S)-tert-butyl (4-(4-phenyl-4,5-dihydrooxazol-2-yl)phenyl)carba-
4.47–4.53 (1H, m), 4.68–4.75 (1H, m), 6.67–6.70 (2H, d,
J = 8.5 Hz), 7.93–7.95 (2H, d, J = 8.5 Hz). C NMR (75 MHz, CDCl ):
3
d (ppm) = 12.8, 13.8, 25.4, 67.8, 110.0, 127.8, 128.1, 143.4, 148.9
C
MS m/z (%): 204 (23.1, M), 179 (9.6), 161 (100), 133 (55.8), 120
1
13
mate (7a): H NMR (300 MHz, CDCl
3
): d
.24–4.30 (1H, t, J = 8.2 Hz), 4.76–4.82 (1H, t, J = 9.2 Hz), 5.34–
.40 (1H, dd, J = 8.4, 9.7 Hz), 6.83 (1H, s, NH), 7.328–7.36 (5H, m,
H
(ppm) = 1.54 (9H, s),
4
5
1
3
Ar), 7.44–7.47 (2H, d, J = 8.6 Hz), 7.96–7.99 (2H, d, J = 8.6 Hz);
NMR (75 MHz, DMSO-d
C
(86.5), 106 (57.7), 92 (28.8), 85.2 (19.2), 77 (40.4), 72 (75).
D
6
): d
C
(ppm) = 28.5, 56.3, 65.0, 79.9, 117.5,
[a]
20 = +27.6° (c 1.0, CH
2
Cl
2
).
1
27.4, 128.5, 128.7, 139.1, 142.0, 142.7, 153.1, 166.1; IR (KBr,
(S)-4-(4-isobutyl-4,5-dihydrooxazol-2-yl)aniline (8d): 1H NMR
(300 MHz, CDCl ): d (ppm) = 0.96–0.99 (6H, m), 1.48–1.58 (1H,
ꢁ
1
cm ): 1516, 1630, 1710, 2920, 2977, 3357
S)-tert-butyl (4-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)carba-
3
H
(
m), 1.77–1.91 (2H, m), 4.48–4.63 (2H, m), 4.93–5.10 (1H, m),
6.65–6.67 (2H, d, J = 8.5 Hz), 7.90–7.92 (2H, d, J = 8.5 Hz). MS m/z
1
mate (7b): H NMR (300 MHz, CDCl
3
): d
.71–2.79 (1H dd, J = 13.5, 9.0 Hz), 3.23–3.30 (1H, dd, J = 13.7,
.7 Hz), 4.13–4.18 (1H, t, J = 7.6 Hz), 4.32–4.38 (1H, t, J = 8.8 Hz),
H
(ppm) = 1.54 (9H, s),
2
4
(%): 218 (M, 2.5), 203 (1), 161 (25), 120 (44), 85 (64), 71 (97), 57
D
(100). [a]
20 = +14.3° (c 1.0, CH
2
Cl
2
).